Jean Marie Vianney Habarugira

Senior Project Officer

 

As a Senior Project Officer at EDCTP, Jean Marie Vianney Habarugira manages Calls for Proposals and EDCTP-funded grants. He is responsible for the EDCTP Emerging diseases portfolio, including the COVID-19 emergency funding mechanism and other large-scale projects on epidemic preparedness.

Born and raised in Burundi, Jean Marie Vianney moved to Russia in 2000 for his graduate and post-graduate studies. In 2006, he obtained a Master of Science in Pharmacy at the Volgograd State Medical University, in Russia. He then moved to The Netherlands where he obtained a Bachelor’s Degree in Business Administration at the NHL University in Leeuwarden before continuing his life sciences research at the Utrecht University, in a Drug Innovation Master’s programme with a focus on Drug Discovery, Drug Development and Regulatory Affairs. He carried out research projects for the KNCV Tuberculosis Foundation exploring measures for TB infection control among healthcare workers, for the Dutch Medicines Evaluation Board where he explored external validity of results from oncology clinical trials. In 2009-2010, prior to joining the EDCTP Calls and Grants Department, he carried out an EDCTP mapping project that served as a rolling inventory of Africa-Europe collaborations in clinical research taking place in Sub-Saharan Africa.

After joining EDCTP in 2010 he continued pursuing his professional development and academic interests, completing a Master’s in Pharmacovigilance and Pharmacoepidemiology at the European Programme in Pharmacovigilance and Pharmacoepidemiology (Eu2P), where he focussed on safety reporting from clinical trials conducted in resource-limited settings. He regularly performs peer reviews for journals in the areas of drug safety and epidemic preparedness. Jean Marie Vianney is also affiliated with the Autonomous University of Barcelona, Spain, pursuing a PhD in Pharmacology with a project that seeks to propose innovative antimicrobial stewardship strategies, using the knowledge that cuts across the areas of Pharmacovigilance and Antimicrobial Resistance.

(The Hague Office)